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Abstract
Background: Protein enrichment by sub-cellular fractionation was combined with differential-in-gel-electrophoresis
(DIGE) to address the detection of the low abundance chromatin proteins in the budding yeast proteome.
Comparisons of whole-cell extracts and chromatin fractions were used to provide a measure of the degree of
chromatin association for individual proteins, which could be compared across sample treatments. The method
was applied to analyze the effect of the DNA damaging agent methyl methanesulfonate (MMS) on levels of
chromatin-associated proteins.
Results: Up-regulation of several previously characterized DNA damage checkpoint-regulated proteins, such as
Rnr4, Rpa1 and Rpa2, was observed. In addition, several novel DNA damage responsive proteins were identified
and assessed for genotoxic sensitivity using either DAmP (decreased abundance by mRNA perturbation) or
knockout strains, including Acf2, Arp3, Bmh1, Hsp31, Lsp1, Pst2, Rnr4, Rpa1, Rpa2, Ste4, Ycp4 and Yrb1. A strain in
which the expression of the Ran-GTPase binding protein Yrb1 was reduced was found to be hypersensitive to
genotoxic stress.
Conclusion: The described method was effective at unveiling chromatin-associated proteins that are less likely to
be detected in the absence of fractionation. Several novel proteins with altered chromatin abundance were
identified including Yrb1, pointing to a role for this nuclear import associated protein in DNA damage response.
Keywords: chromatin, fractionation, DIGE, differential, proteomics, MMS, DNA damage
Background
Within many proteomic studies, protein abundance and
complexity can affect practical detection sensitivity, even
with advances in differential in-gel electrophoresis (DIGE)
[1] and MS-based approaches [2]. For example, certain
functional classes of proteins such as transcription factors
and cell cycle proteins are present at low abundance in
whole cell extracts compared to other structural and meta-
bolic proteins [3]. In response to the issues of low abun-
dance and dynamic range limitations of quantitative
proteomics methods (e.g. LC-MS or DIGE), one strategy is
to minimize sample complexity through enrichment
approaches, such as affinity capture of protein complexes
(e.g. tandem affinity purification) [4], selection of phospho-
peptides [5], and sub-cellular fractionation [6-8]. Although
targeted affinity-based methods can lead to high levels of
enrichment, they have a high probability of excluding rele-
vant proteins. An attractive alternative approach is a sub-
cellular fractionation, where overall protein complexity
and stoichiometry can be largely retained during the frac-
tionation. Based on this rationale, cellular organelles have
been subjected to proteomic analysis, including mitochon-
dria and chloroplasts [6-8], demonstrating that the combi-
nation of sub-cellular fractionation and proteomics
techniques provides a practical means for the analysis of
low-abundance proteins localized in discrete regions of
the cell.
Though it is not a separate organelle per se, chromatin
is physically organized in the cell and, due to the impor-
tance of chromatin in molecular analyses of DNA replica-
tion and epigenetics, procedures to separate chromatin
from other cellular components have become well estab-
lished in budding yeast [9-11]. By using fractionated chro-
matin samples, MS-based approaches have been employed
to identify a wide range of chromatin-associated proteins,
including those from developing Xenopus embryos [12]
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dies based on chromatography and/or mass spectrometry-
based analysis of digested peptides, initial fractionation
coupled with downstream proteomics methods is extre-
mely valuable for addressing the relatively low abundance
of many chromatin-associated proteins, especially in the
context of large-scale protein identification. However, it
can still be challenging to address differential expression
using fractionated chromatin, as technical variability dur-
ing its preparation can interfere with multiplex sampling
and stringent statistical evaluation is needed to minimize
false discovery rates. In addressing this aspect, gel-based
proteomics is a promising approach to accommodate mul-
tiplex experimentation effectively while minimizing sys-
temic experimental variation. In addition, the DIGE
method is extremely useful for identifying various protein
forms resulting from posttranslational modifications such
as phosphorylation [14] and evaluating their relative
abundance.
Chromatin-associated proteins mediate a multitude of
biological processes such as DNA replication, repair, and
transcription [15-17], through complex regulatory
mechanisms. The structure of chromatin changes as a
function of the cell cycle, adopting a more condensed con-
formation during mitotic phase relative to interphase,
when DNA is duplicated. When chromatin integrity is
compromised as a result of exposure to genotoxic agents,
the cellular repair machinery is recruited to sites of DNA
damage [18,19]. The appropriate regulation of each pro-
cess requires a multitude of mechanisms such as histone
modification [20], chromatin remodeling [21], and forma-
tion of diverse protein complexes. In studies of biological
mechanisms, the qualitative and quantitative analyses of
interactions and/or binding with chromatin are crucial in
order to investigate protein function, signaling pathways,
and modular networks [22]. Therefore, global proteomic
profiling of chromatin provides an effective means to gain
valuable information about these central biological pro-
cesses [22], and has widespread applications such as accel-
eration of pharmaceutical development [20].
In this study, we have conducted an analysis of differ-
ential protein expression using 2D-DIGE in combination
with chromatin fractionation of budding yeast. We first
assessed the effectiveness of our approach in isolating
and detecting chromatin-associated proteins using DIGE.
The combination of DIGE with fractionation allows both
identification of differential abundance due to an applied
treatment, and additionally provides a means to estimate
changes in protein localization, or in this case, chromatin
affinity. The potential utility of this novel approach was
then confirmed by applying the method to screen for dif-
ferentially expressed proteins following treatment with
the DNA damaging methyl methanesulfonate (MMS),
resulting in the detection of both known and novel DNA
damage response proteins.
Results and discussion
Initial DIGE based identification of chromatin fraction
proteins
Yeast protein extracts from whole cells and from chroma-
tin enrichment were compared using DIGE. Candidate
proteins were selected for identification on the basis of
chromatin enrichment factor (EF), defined for a given spot
as the average ratio of spot volume in the chromatin frac-
tion vs. the whole cell extract in DIGE images [Additional
File 1, Figure S1]. Enrichment factors were calculated for
paired chromatin and WCE samples in the four DIGE gels
using the BVA analysis module within the DeCyder™
software package. P-values were also calculated for protein
spots, but as two different sample types are being com-
pared these provide only a relative measure of variability
and enrichment. As the initial fractionation procedure
retained 2.1% of the total cellular protein on average, the
theoretical upper limit of the enrichment factor is approxi-
mately 50 fold.
To verify that the fractionation was successful at target-
ing chromatin-associated proteins, a subset of enriched
protein spots was analyzed by mass spectrometry. A Coo-
massie-stained gel was prepared from a chromatin-
enriched yeast fraction for protein identification (Figure 1).
Spots with an experimental enrichment factor greater than
1.4 fold were selected for MS analysis, and 33 of these were
identified (Table 1, Additional File 1, Tables S1). Based on
annotations from the Saccharomyces Genome Database
http://www.yeastgenome.org, the organelle database http://
organelledb.lsi.umich.edu, and literature sources, the
majority have been previously identified as localizing to the
nucleus and include many functionally important chroma-
tin proteins. Estimated protein copy number per cell [3] is
shown in Table 1 for known chromatin-associated proteins
identified in the chromatin fraction [Additional File 1,
Figure S1]. Overall, the fractionation procedure was effec-
tive at enriching low-abundance chromatin associated pro-
teins. Interestingly, a number of the identified proteins had
very low expected cellular levels (e.g. 1070 copies/cell for
Arp4 and 1360 for Arp7) based on previous GFP fusion
experiments [3].
Among the identified proteins, some belong to well-
known complexes involved in chromatin remodeling, such
as SWI/SNF and INO80 [23]. These include Swi3, Taf14,
Arp4, Arp7, Arp9, and Rvb2. Members of RNA polymer-
ase complexes [24,25] were also identified, including the
proteins Rpc40, Rpb3, and Tfc7. In addition, some pro-
teins important for telomere capping and remodeling were
found, such as Stm1 [26] and Cgi121 [27]. In many cases,
proteins were identified along with other factors they
normally interact with, implying good retention and
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suggests that chromatin fractionation was effective at
enriching for functional chromatin proteins.
Changes in chromatin fraction due to MMS treatment
To further investigate differential profiling of chromatin-
associated proteins, we examined the response to MMS-
induced changes in budding yeast. A well-studied
genotoxic agent, MMS alkylates DNA and results in activa-
tion of the DNA damage checkpoint, initially with detec-
tion of DNA damage, followed by a signaling cascade
which results in the phosphorylation of protein targets
involved in cell cycle control, DNA replication and repair
[18,19]. Comparison of chromatin fractions from MMS
treated and control samples should indicate proteins that
are differentially regulated and/or have a greater degree of
chromatin association in response to MMS.
Four independent replicates of cultures were made for
untreated samples and samples treated with 0.03% MMS,
and chromatin enrichment was conducted as before.
Differential protein abundance in the chromatin fraction
was compared between MMS treated and control sam-
ples using DIGE [Additional File 1 Figure S2]. Addition-
ally, whole-cell extracts and chromatin fractions were
compared to calculate protein enrichment factors in the
presence of MMS. The statistical power of detecting
changes in abundance was also estimated, and at a statis-
tical power of 0.8 (b =0 . 2 )w i t ha = 0.05, the four DIGE
gels can theoretically be used to identify a change of 1.43
fold in spot abundance with a success rate of 80%. The
normalized standard deviation of protein spots present
on all gels was 0.216 for untreated samples and 0.220 for
the MMS treated samples. Differential factor (DF) values
for MMS treatment were determined through quantifica-
tion using the DeCyder™ v.6.0 software as described in
Experimental Procedures, with DF calculated from the
ratio of the protein in the MMS treated sample vs. the
control sample. Here, DF includes contributions from
both expression and changes in localization; for example,
if DF increases but the EF ratios for the MMS+ treated
Figure 1 2D-protein spot map of the yeast chromatin fraction. Representative proteins enriched in the chromatin fraction were identified by
mass spectrometry and are marked with corresponding protein names. Protein identification data are summarized in Additional File 1, Table S1
with respective chromatin enrichment factors and p-values.
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Protein
name
Enrichment factor Estimated
copies/cell
a
Cellular Localization
b Description
c
Arp3 +1.74 6650 Cytoskeleton, Nucleus [54] Actin-related protein 3,
actin filament organization
Arp4 +4.20 1070 Nucleus Actin-related protein 4,
chromatin remodeling
Arp7 +2.53 1360 Nucleus Actin-related protein 7,
chromatin remodeling
Arp9 +3.35 1790 Nucleus
d Actin-related protein 9,
chromatin remodeling
Asc1 +2.88 333000 Cytoplasm G protein beta subunit,
Small subunit ribosomal protein
Atp2 +1.43 164000 Mitochondrion F1-ATPase beta chain, mitochondrial ATP synthesis
Cdc10 +3.09 14100 Septin ring, cytosketelon,
nucleus
d
Septin ring protein, cell division
Cgi121 +3.37 N.D. Nucleus [27] Component of KEOPS, telomere uncapping and elongation
Crn1 +4.06 2900 Contractile ring,
Cytoskeleton
d
Coronin,
actin filament organization
Cys3 +1.65 38300 Cytoplasm Gamma-cystathionase, Cysteine biosynthesis
Egd2 +1.55 38000 Cytoplasm, Nucleus [55] Component of NAC, ribosome associated
End3 +10.4 2600 Cytoskeleton EH domain protein, actin cytoskeletal organization
Gdi1 +1.58 7280 Cytoplasm GDP dissociation inhibitor, vesicle mediated transport
Ilv2 +13.4 31900 Mitochondrion Acetolactate synthase, amino acid synthesis
Ilv5 +1.95 883000 Nucleus, Mitochondrion
d Acetohydroxy-acid isomerase, amino acid synthesis
Lat1 +2.42 5440 Mitochondrion Dihydrolipoamide acetyl-transferase, pyruvate metabolism
Lsp1 +5.54 104000 Cytoplasm (punctate
composite)
Component of eisosome, endocytosis
Pdb1 +3.93 9970 Mitochrondrion, Nucleoid
d Pyruvate dehydrogenase, pyruvate metabolism
Pil1 +1.65, Pil1(a) +2.31,
Pil1(b)
115000 Cytoplasm (punctate
composite)
Component of eisosome, endocytosis
Pst2 +3.37 2330 Mitochondrion,
Nucleus [56]
Flavodoxin-like protein
Qcr2 +1.73 35700 Mitochondrion Ubiquinol cytochrome C reductase, respiration
Raf1 +3.37 N.D. Nucleus [57] FLP1recombinase activating factor, plasmid maintenance
Rpb3 +3.38 10000 Nucleus DNA directed RNA polymerase II
Rpc40 +3.98 13000 Nucleus Component of RNA polymerases I
Rpt1 +1.92 105 Nucleus ATPase subunit of proteosome
Rvb2 +4.03 3030 Nucleus
d Transcription, chromatin remodeling
Stm1 +2.21 46800 Cytoplasm, Nucleus
d TOR signaling, telomere structure
Swi3 +6.85 3150 Nucleus Chromatin remodeling complex, SWI/SNF
Taf14 +4.32 3120 Nucleus Subunit of TFIID, TFIIF, INO80, SWI/SNF, NUA3 complexes,
chromatin remodeling
Tfc7 +3.89 2660 Cytoplasm, Nucleus RNA polymerase IIIc
Tub2 +3.73 N.D. Nucleus, Cytoskeleton
d Tublin 2, microtubule component
Ume1 +2.22 3040 Cytoplasm, Nucleus Negative regulator of meosis, binding to histone deacetylase
RPD3.
Ura7 +3.73 57600 Cytoplasm CTP synthase, phospholipid biosynthesis
DIGE was used to compare the chromatin fraction vs. whole cell yeast extract, and protein spots with an enrichment factor greater than +1.40 were selected for
identification.
a - Protein copy numbers per cell are from Ghaemmaghami et al. (2003) [3], obtained via the Saccharomyces Genome Database http://www.yeastgenome.org.
b - unless otherwise noted, localizations were obtained from Huh et al (2003) [58] via the Saccharomyces Genome Database.
c- functional descriptions were obtained from the Saccharomyces Genome Database.
d- localization was obtained from the organelle database http://organelledb.lsi.umich.edu.
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to expression. It is also possible that DF to be positive
and the EF ratio to decrease, indicating an increased pro-
tein expression and increased amount in the chromatin
fraction, but a larger increase in non-chromatin asso-
ciated protein. A total of 1763 spots were matched across
the four replicates in the differential MMS experiment, of
which 455 showed significant changes (increased or
decreased) at p < 0.05 with FDR correction. Comparing
the calculated EF values from chromatin enrichment for
these 455 spots, 217 were both differentially regulated
and enriched in chromatin fractions.
Identification of MMS responsive proteins
Protein spots from the MMS DIGE experiment were
prioritized for identification according to the degree of
chromatin enrichment (EF) and changes in observed
abundance (’differential factor’, DF). Spots that showed
both positive EF and DF values (among the 217 described
above) were of particular interest, as they indicated both
chromatin-association and induction by MMS treatment,
respectively. A preparative Coomassie-stained gel was
made using chromatin fractions of the MMS treated sam-
ples (Figure 2), and protein spots were excised for identifi-
cation by mass spectrometry. Identifications were made
for 23 DF+ proteins and 12 DF- proteins (Table 2, Addi-
tional File 1, Table S2). A subgroup of identified proteins
corresponds to known checkpoint-regulated proteins,
including Rnr4, Rpa1, and Rpa2. Rpa1 and Rpa2 are subu-
nits of the hetero-trimeric replication factor A complex,
which plays an integral role in DNA replication and
checkpoint responses [19,28-30]. Among the spots with
negative enrichment factors, Rnr4 isoforms exhibited
some of the largest responses to MMS treatment as
reflected by DF values (Table 2). The RNR complex con-
trols the nucleotide pool for DNA synthesis and is a
downstream target of the Rad53 checkpoint kinase [31,32].
Along with the previously well-characterized proteins
above, several additional DNA damage-associated proteins
were identified as differentially expressed on MMS treat-
ment including Bmh1, Pst2 Vma2, and Vma4 (see Table
2). Bmh1 is a 14-3-3 protein family member, which has
been shown to directly modulate Rad53 activity [33]. Pst2,
a predicted oxidative response protein, has also been impli-
cated in DNA damage responses [29]. Vacuolar-type H+
ATPase subunits Vma2 and Vma4 have been shown to
play a role in DNA damage responses following treatment
with MMS and cisplatin [34]. In addition, several other
proteins were identified that have not been well character-
ized in terms of their potential role following DNA
damage, including Acf2, Arp3, Hsp31, Lsp1, Ste4, Ycp4,
and Yrb1. Several proteins with low chromatin association
(low EF values) and showing a differential response to
MMS treatment were also identified (Table, 2, Additional
File 1, Table S2). While these proteins are not chromatin
associated per se, some (e.g. metabolic enzymes Ald6 and
Pdc1) are consistent with a stress response in which yeast
cells have a lowered metabolic activity and concomitant
reduced growth competency. This observation is consistent
with the model of suppressed protein synthesis upon DNA
damage checkpoint execution or cellular stress [35]. It is
also possible that for some of these factors the effect of
MMS may not have been due to DNA damage, since this
alkylating agent can also act directly on proteins [36,37]. A
number of key DNA damage response factors including
the kinases Mec1, Tel1, Rad53 and Chk1, and members of
the 9-1-1 complex (Rad17, Mec3, Ddc1) (reviewed in [19])
were not among the proteins that we identified in this
screen. However, this is not surprising as we characterized
only a subset of proteins that were chromatin- and/or
MMS-enriched in our samples.
Changes in chromatin association and localization due to
MMS treatment
The MMS DIGE experiment provided a direct measure of
changes in protein abundance within the chromatin
enriched fraction. This can represent a change in expres-
sion of the protein of interest, a change in the degree of
chromatin association (including direct binding to DNA,
interaction with DNA binding proteins, or simple inclu-
sion in the chromatin pellet), or some combination of
these factors. Here, the calculated EF ratios for MMS trea-
ted and control samples can be compared and changes in
EF values can provide an estimate of changes in the degree
of chromatin association (i.e. localization). The EF ratios
for the control (MMS-) and treated (MMS+) samples are
compared in Figure 3. The majority of proteins increased
their degree of chromatin association in response to MMS
treatment. Interestingly, different forms of the same pro-
tein often exhibited different changes in expression and
chromatin association, including Rnr4, Vma2, Pst2, Lsp1,
Ycp4, Cdc10 and Bmh1 (Table 2, Additional File 1, Table
S2). For example, four isoforms of Rnr4 were detected, all
of which increased in chromatin abundance in response to
MMS treatment [Additional File 1, Figure S2]. Rnr4 was
previously reported to undergo increased translocation to
the cytoplasm under genotoxic stress [32]. Consistent with
this, we find that the isoform with the highest chromatin
association, Rnr4-d, showed a decrease in the proportion
of Rnr4-d associated with chromatin on MMS treatment
as reflected by the decrease in enrichment factor from
+1.30 to -1.06. However, the total amount of all forms of
Rnr4 binding chromatin increased, as all forms had posi-
tive DF values. The most abundant isoform, Rnr4-b [Addi-
tional File 1, Figure S2], had minimal association with
chromatin with or without MMS treatment (Table 2). The
observed values of DF and EF indicate a complex
response, with some isoforms increasing and others
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while the total amount of cellular Rnr4 apparently increas-
ing on MMS exposure.
All Vma2 isoforms demonstrated greater chromatin
association (EF) as a consequence of MMS treatment, but
isoforms Vma2-a and b, showed a more dramatic increase
than Vma2-c. Comparing the DF and EF values in Table
2 ,t h ec h a n g ei nc h r o m a t i nabundance can be largely
attributed to an increase in chromatin association for
Vma2 as opposed to increased cellular protein levels. Simi-
larly, Rpa1 demonstrated a pronounced increase in chro-
matin association on MMS exposure, suggesting that the
observed increase in chromatin abundance (DF) can be
largely attributed to a change in cellular localization
(Table 2). Conversely, Cdc10-b exhibited a small net
increase in abundance in the chromatin fraction on MMS
treatment (DF +1.38) but a decrease in EF from +2.43 to
+1.50. This is consistent with an increase in cellular
expression of Cdc10-b, but a smaller proportion of Cdc10-
b associating with chromatin.
It has previously been observed that genes that are
induced by DNA damaging agents are not those that are
identified as protecting cells against DNA damage [38].
However, as proteins can respond more rapidly than
genes through post-translational modifications or
changes in localization, there may be a closer relationship
between increased chromatin association and DNA-pro-
tective proteins. In contrast to gene expression data [38],
we find that almost half of the proteins identified (10 of
22) were previously identified as responding to genotoxic
agents in high-throughput screening studies. Specifically,
acf2, aim13, gcv3,a n dycp4 knockout strains were identi-
fied as having significant fitness defects (p < 0.05) on
MMS exposure, with aim13, bmh1, cdc10, cps1, gcv3,
pil1, pst2, rnr4 knockout strains having fitness defects on
exposure to hydroxyurea [39].
Figure 2 2D-protein spot map showing differentially expressed proteins identified in the MMS treated yeast chromatin fraction.
Proteins with statistically significant changes abundance on MMS treatment were identified by mass spectrometry and are marked with
corresponding protein names. Protein identification data are summarized in Additional File 1, Table S2.
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Protein name DF p-value
(DF)
EF (+MMS) p-value
(EF, +MMS)
EF (-MMS) p-value
(EF, -MMS)
Acf2 +1.48 0.020 +1.57 0.011 -1.30 0.048
Aim13 +1.70 0.0053 +3.30 0.034 +2.27 0.00097
Arp3 +1.35 0.024 N/A N/A +1.52 0.063
Atp2 +1.52 0.0093 +1.50 0.093 +5.74 0.000041
Bmh1 (a) +1.92 0.0014 +3.57 0.0039 -1.03 0.070
Cdc10 (a) +1.61 0.0034 +7.28 0.0099 +6.33 0.000015
Cdc10 (b) +1.38 0.044 +1.50 0.18 +2.43 0.0015
Cps1 +1.61 0.010 +2.16 0.0036 -2.57 0.00018
Crn1 +1.78 0.0034 +3.85 0.0024 +2.36 0.0012
Gcv3 +1.75 0.019 +1.07 0.52 -1.90 0.00087
Ilv2 +2.15 0.013 +1.50 0.39 -1.15 0.086
Lsp1 (a) +1.51 0.0023 +3.17 0.0011 +1.79 0.022
Lsp1 (b) +1.84 0.0046 +3.69 0.00072 -1.71 0.0078
Nsp1 +1.58 0.0050 +3.07 0.014 +1.65 0.017
Pil1 +2.05 0.0013 +9.60 0.0068 +2.65 0.036
Pst2 (a) +1.50 0.0023 +3.99 0.0074 +1.55 0.0019
Pst2 (b) +3.83 0.0013 +4.50 0.0074 -1.02 0.14
Rpa1 +3.58 0.00070 +4.16 0.010 -1.33 N/A
Rpa2 +1.47 0.036 +2.50 0.015 -1.12 0.089
Ste4 +1.61 0.023 +2.32 0.000092 -1.00 0.16
Vma2 (a) +1.92 0.0052 +1.59 0.0063 -1.34 0.00019
Vma2 (b) +1.48 0.018 +1.64 0.0041 -1.58 0.00018
Vma2 (c) +1.53 0.0097 +1.65 0.021 +1.10 0.050
Vma4 +1.85 0.010 +1.58 0.0048 -1.08 0.070
Ycp4 (a) +2.01 0.00070 +5.40 0.00073 +1.76 0.00050
Ycp4 (b) +1.69 0.037 +5.31 0.00063 +1.18 0.13
Yrb1 +2.05 0.025 +5.07 0.0011 +1.77 0.0040
Hsp31 +1.63 0.0063 -1.64 0.0051 -1.84 0.000062
Rnr4 (a) +1.91 0.0014 -1.24 0.25 -1.47 0.013
Rnr4 (b) +3.90 0.000057 -2.08 0.012 -3.11 0.00011
Rnr4 (c) +3.89 0.000057 -1.17 0.27 -2.23 0.00025
Rnr4 (d) +2.41 0.0023 -1.06 0.74 +1.30 0.015
Ald6 -1.84 0.00056 -2.21 0.021 -1.81 0.00014
Bgl2 -1.85 0.00068 -1.54 0.17 +7.02 0.000022
Bmh1 (b) -1.43 0.0020 -1.53 0.0071 -1.07 0.059
Bmh2 -1.90 0.0020 -2.08 0.021 -1.06 0.069
Hsp60 -1.72 0.00017 -1.56 0.091 +1.31 0.0079
Pdc1 -1.69 0.00022 -2.27 0.013 -2.64 0.000099
Rpc40 -1.53 0.0016 +2.31 0.013 +3.98 0.000015
Rpp0 -1.70 0.00056 -2.15 0.028 -1.61 0.00037
Ssb1 -1.62 0.0084 -1.41 0.12 -1.27 0.00027
Ssb2 -1.83 0.0092 +2.01 0.018 +1.45 0.0090
Tma19 -1.93 0.0027 -3.00 0.036 -1.02 0.14
Ura7 -1.85 0.0027 +6.01 0.059 +3.73 0.000022
Multiple protein isoforms are indicated with a, b, c and d in parentheses. DF, differential factor, is fold change in abundance in the chromatin fraction on MMS
treatment, where +DF indicates an increase and -DF a decrease. EF is the chromatin enrichment factor relative to the whole cell extract in either treated (MMS+)
or control (MMS-) samples. See Additional File 1, Table S2 for MS/MS identification data.
a p-values are calculated using DeCyder 6.0 with FDR correction, from four biological replicates.
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yeast strains
To further investigate MMS induced proteins identified
via the DIGE analysis, yeast strains with mutations corre-
sponding to the genes encoding several of these proteins
were evaluated in growth assays in the presence of the
genotoxic agents MMS or HU [40,41]. Haploid cells
either containing gene knockouts (pst2, bmh1, hsp31,
acf2, ste4, rnr4) or, in the case of essential genes, lowered
mRNA expression due to reduced mRNA stability,
(DAmP strains, Open Biosystems) (rpa1, rpa2, yrb1,
arp3) were employed. We used an isogenic wild-type
strain as a negative control and a rad53-11 strain [42]
with a mutant allele in the checkpoint kinase Rad53 as a
positive control for sensitivity to genotoxic agents.
We were primarily interested in proteins increasing in
chromatin abundance, however haploid yeast knockout
strains corresponding to a number of proteins decreasing
in abundance were also investigated [Additional File 1,
Figure S3]. None of these strains showed either enhanced
or reduced susceptibility to MMS or HU relative to the
isogenic wild-type strain. Among the strains correspond-
ing to proteins with increased chromatin abundance
(Figure 4), acf2, arp3, hsp31,a n dycp4 mutants did not
Figure 3 Chromatin Enrichment Factors (EF) in the presence and absence of MMS. Enrichment factors were calculated from the ratio of
protein abundance in the chromatin fraction versus whole cell extract. A general increase in chromatin association is seen with MMS treatment,
along with changes specific protein to given protein isoforms including Rnr4, Vma2, Pst2, Cdc10, Ycp4, Bmh1 and Lsp1.
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type strain. Interestingly, pst2, ste4,a n dlsp1 mutants
actually exhibited increased resistance to MMS, indicat-
ing a link to the DNA damage response, possibly through
interrelated pathways such as MAP kinase signaling, eiso-
some trafficking and oxidative stress response. rpa1, rpa2
and rnr4 mutants have previously been shown to be sen-
sitive to MMS or HU, in agreement with their DNA
damage checkpoint regulation [29-32]. Here however, no
significant response was seen for rpa1 or rpa2 DAmP
strains to MMS treatment and rpa1 to HU treatment.
Subsequent western blot analysis of Rpa1 levels revealed
that it was not reduced in the rpa1 DAmP strain relative
to the isogenic wild-type (results not shown), accounting
for the lack of sensitivity observed. Given that the rpa2
DAmP strain was sensitive to HU, its Rpa2 level
presumably was reduced compared to wild-type, however
it may not have been sufficiently diminished to render
cells more vulnerable to the effects of MMS. The rnr4
knockout strain similarly did not show increased geno-
toxic sensitivity. It is possible that other RNR genes may
compensate for rnr4 DAmP cells showed pronounced
sensitivity to MMS (at more than 0.02%) and HU (at
more than 25 mM). The Yrb1 protein in budding yeast
has not been well characterized to date, but has been
proposed to be a Ran-GTPase binding protein involved
in nucleocytoplasmic transport [43].
Conclusions
We have combined the differential proteomics technique
of DIGE with a chromatin fractionation and enrichment
strategy, and applied it to investigate the response to
Figure 4 Spotting growth assay for genotoxic sensitivity. The yeast cells were either knockout (ycp4, lsp1, pst2, bmh1, hsp31, acf2, ste4,a n d
rnr4) or DAmP strains (rpa1, rpa2, yrb1 and arp3). The assay was performed on YPD plates containing indicated concentrations of MMS or HU.
Cells were 10-fold serially diluted and incubated at 30°C for 2 days. An isogenic wild-type strain BY4741 was used as a negative control and
rad53-11 mutant strain as a positive control.
Kim et al. Proteome Science 2011, 9:62
http://www.proteomesci.com/content/9/1/62
Page 9 of 14genotoxic agents in budding yeast cells. Our approach
facilitated the selective screening of important chromatin-
associated proteins that can otherwise be difficult to
observe by typical proteomics approaches, and was suc-
cessful in identifying functionally relevant target proteins.
Moreover, the method was effec t i v ef o rt h ed i f f e r e n t i a l
analysis of yeast cells following chemical treatment, as
demonstrated by the MMS exposure experiment. While
the fractionation method used was effective at enrichment
of chromatin binding factors, a number of the observed
proteins were likely mitochondrial, suggesting that more
specific fractionation methods could be applied. One pos-
sible approach would be to first isolate nuclei prior to
chromatin enrichment. Overall, the described method was
successful in permitting the differential analysis of chro-
matin binding proteins using a gel-based proteomics tech-
nique, largely overcoming the technical limitations for
analyzing lower-abundance chromatin proteins.
While the methodology was effective at identifying
known and potentially novel proteins involved in DNA
damage response, the technique does not provide compre-
hensive coverage. Future refinements to the methodology
may be able to increase the number of factors identified in
similar studies. The gel methods could be expanded to
increase the pH range over which proteins can be sepa-
rated effectively, more sensitive mass spectrometers may
be used to increase the success rate of protein identifica-
tion, a greater degree of replication and experimental pre-
cision may be utilized to detect proteins undergoing small
changes in abundance and/or localization.
Characterization of differentially expressed proteins
based on DF analysis was extended using an analysis of
the chromatin enrichment factors (EF), providing a quan-
titative estimate of protein localization not typically avail-
able within proteomics studies. The method was also
informative in addressing changes in protein localization,
as demonstrated in the change of enrichment factor
depending on treatment. Chromatin fractionation was
able to consistently reveal a large population of chroma-
tin-associated proteins using a relatively straightforward
sampling procedure, in which intact complexes are main-
tained, as indicated by the co-detection of functionally
related chromatin proteins (i.e. Tables 1 and 2). A techni-
cal strength of DIGE itself, compared to MS-based meth-
ods, is that it is able to distinguish differences in response
to compounds such as MMS for different protein iso-
forms or post-translational variants, as revealed in the
Rnr4 isoforms in this study. In contrast, quantitative MS-
based methods largely rely on digested peptides [44],
making it more challenging to distinguish variable forms,
as the peptides on which the change is located need to be
correctly identified, quantified, and compared with pep-
tides representing other forms of the protein.
With respect to the budding yeast DNA damage
response, this study was in broad agreement with previous
high-throughput studies on this response, using a variety
of approaches such as microarray analysis [45], phenotyp-
ing of deletion strains [46] and quantitative phosphopro-
teomics [5]. The microarray study showed the over-
expression of the RNR complex (which is composed of
four subunits Rnr1, Rnr2, Rnr3 and Rnr4) as the most sig-
nificantly changed along with other key proteins such as
Din7, Dun1, Rad54 and Rad51. The phosphoproteome
study screened the possible phosphorylation-mediated tar-
gets of Mec1/Tel1 and Rad53 kinases [5], and identified
proteins involved in DNA replication, cytokinesis, tran-
scription, mitosis, RNA export, stress response, transcrip-
tion, and nuclear transport. Compared to the above
studies, our approach focused on a subset of the budding
yeast proteome that is highly associated with chromatin.
In addition to the confirmation of known checkpoint-
regulated factors (e.g. Rpa1, Rpa2, Rnr4), several new pro-
teins related to DNA damage response pathways have
been identified. One such factor is the Ran-GTPase bind-
ing protein Yrb1, a component of the nuclear import-
export system [43], in which the ternary complex of Gsp1,
Yrb1 and Rna1 controls the GTP/GDP balance across the
nuclear membrane. We propose here that Yrb1 protein
may represent a link between the nuclear transport system
and DNA damage responses, as implied by a recent model
for G1-S cell cycle arrest during checkpoint execution
[47]. It will now be of interest to determine which proteins
dependent on Yrb1-mediated nucleocytoplasmic traffick-
ing act downstream of this factor in affording protection
to genotoxic agents.
I nc o n c l u s i o n ,w ep r e s e n tas i m p l ef r a c t i o n a t i o na n d
DIGE-based approach for chromatin proteomics, which
can be broadly applied to investigate biological responses
to chemical stress and other factors. This method was suc-
cessfully applied to investigate changes that occur follow-
ing exposure to the genotoxic agent MMS, confirming
that it is effective in identifying novel proteins involved in
cellular processes, such as the response to DNA damage.
Methods
Yeast strains
Wild-type haploid Saccharomyces cerevisae strain BY4733
(MATa, his3Δ200, leu2Δ0, met15Δ0, trp1Δ63, ura3Δ0),
purchased from Open Biosystems (Thermo Fisher Scienti-
fic Inc.), was used for all DIGE experiments. For genotoxic
sensitivity assays, wild-type haploid strain BY4741 (MATa,
his3Δ1, leu2Δ0, met15Δ0, ura3Δ0 ) ,i s o g e n i cM A T ah a p -
loid DAmP strains YAR007c (rpa1), YNL312w (rpa2),
YDR002w (yrb1), YJR065c (arp3), and isogenic haploid
knock-out strains YCR004c (ycp4), YPL004c (lsp1),
YDR032c (pst2), YER177w (bmh1), YDR533c (hsp31),
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purchased from Open Biosystems. A rad53-11 strain
(MATa, ura3, leu2, trp1, his3, rad53-11::URA3) was used
as a control for genotoxic sensitivity [42].
Cell culture
For large-scale cultures, a single colony was used to inocu-
late 10 ml YPD medium (1% yeast extract, 2% peptone, 2%
glucose) in a 50 ml Falcon tube, which was then incubated
at 30°C overnight with shaking. 10-20 μl of saturated seed
culture was transferred to 300 ml YPD medium in a 2 L
flask and incubated with shaking at 30°C until a cell den-
sity of 2-3 × 10
7/ml was achieved. For MMS treatment
experiments, the 300 ml sample was centrifuged, the cell
pellet was resuspended in 600 ml fresh YPD medium, and
then divided equally into two 2 L flasks, and then further
cultured at 30°C for 2 hrs. MMS was added to 0.03% for
one of the flasks, and both were cultured at 30°C for
another 90 min. The final cell density was not more than
3×1 0
7/ml.
Chromatin preparation
Chromatin fractionation was based on the method of
Liang and Stillman [11] with minor modifications. Cell
cultures (300 ml in 2L flask) at a density of ~3 × 10
7/ml
were harvested in six 50 ml Falcon tubes and centrifuged
at 4200 rpm for 5 min, washed with 40 ml dH2O. Cell pel-
lets were resuspended in 5 ml 0.1 M EDTA-KOH (pH
8.0), 10 mM DTT, and incubated in a water bath for
15 min at 30°C. Cells were then centrifuged, resuspended
in 5 ml of YPD, 1.1 M sorbitol 0.5 mg/ml Zymolase 20T™
(Sekagaku, Japan), 0.2 mg/ml Lyticase™ (Sigma), and
incubated in a shaking water bath at 30°C for 20-30 min.
Spheroplasts were collected by centrifugation at 2000 rpm
for 3 min and washed once with 20 ml YPD, 1.1 M sorbi-
tol, and 0.5 mM PMSF. The pellet was resuspended in
1 ml wash buffer (5 mM Tris-HCl (pH 7.4), 20 mM KCl,
2 mM EDTA, 0.12 mM spermidine, 0.05 mM spermine,
1 M sorbitol, 1% thiodiglycol, and Complete Mini™
EDTA-free protease inhibitor cocktail (1 tablet/10 ml)
(Roche)) and transferred to two 1.5 ml centrifuge tubes on
ice. Cells were centrifuged at 300 g for 1 min., washed
twice with wash buffer, and centrifuged again. The pellet
was then resuspended in 0.4 ml of lysis buffer (5 mM
T r i s - H C l( p H7 . 4 ) ,2 0m MK C l ,2m ME D T A ,0 . 1 2m M
spermidine, 0.05 mM spermine, 0.4 M sorbitol, 1% thiodi-
glycol, Complete Mini™ EDTA-free protease inhibitor
cocktail (1 tablet/10 ml) (Roche)) and mixed with 0.5 ml
of lysis buffer containing 2% (v/v) Triton X-100. For whole
cell extracts (WCE), 200 μlo fl y s a t ef r o me a c hs a m p l ew a s
set aside and 2% SDS and 50 mM DTT added to maintain
solubility. The remaining protein suspension was incu-
bated on ice for a minimum of 10 min, followed by centri-
fugation at 16,000 g for 10 min to pellet chromatin, and
the supernatant removed. The quality of the chromatin
fractionation was verified by performing western blots for
aliquots of the initial WCE, as well as chromatin and
supernatant fractions, with antibodies for Orc2 and his-
tone H2B which should both be chromatin-bound, as well
as a-tubulin, which should be in the supernatant [11]
[Additional File 1, Figure S4].
Protein extraction
Chromatin pellets from the chromatin preparation were
resuspended in two volumes of extraction buffer (50 mM
Tris-HCl (pH 8.5), 2% (w/v) SDS, 50 mM DTT), and incu-
bated in a boiling water bath for 10 min. Protein extracts
were separated by centrifugation at 14,000 g for 10 min.
The supernatants were collected then desalted using a 2-D
Clean-Up kit (Amersham Biosciences). Protein pellets
from the 2-D Clean-Up treatment were dissolved in IEF
rehydration buffer (7 M urea, 2 M thiourea, 4% (w/v)
CHAPS). Protein concentration was measured using the
Bio-Rad protein assay (Bio-Rad). Protein yield of the chro-
matin fraction was calculated based on the amount in the
chromatin preparation compared to the total amount in
the WCE. A typical 300 ml culture at ~3 × 10
7cells/ml
yielded approximately 200 +/- 100 μg of protein in the
chromatin fraction.
Differential-in-gel-electrophoresis (DIGE)
DIGE was performed based on recommended protocols of
the manufacturer (GE Healthcare) using minimal labeling
CyDye™ DIGE Fluors of Cy2, Cy3 and Cy5. For the
CyDye™ labeling reaction, 40 μg of protein sample in
50 μl of rehydration buffer containing 25 mM Tris-HCl
(pH 8.5) was used for each dye. 1 μlC y D y e ™ solution
(200 pmol/μl in 100% dimethylformamide) was added to
samples on ice. The reaction was incubated for 40 min on
ice, after which 1 μl of 10 mM lysine was added to stop
the reaction. After incubation for 10 min, three sets of
50 μl samples (labeled with Cy2, Cy3 and Cy5) were com-
bined and mixed with 45 μl of 1 M DTT, 4.5 μlo f1 %
(v/v) IEF buffer 4-7, 1 μl of 1% (w/v) bromophenol blue
(BPB) and 250 μl of the rehydration buffer.
Immobiline™ DryStrip gels (IPG pH4-7/24 cm) (GE
Healthcare) were used for isoelectric focusing as the first
dimensional separation. The strips were passively rehy-
drated with 450 μl of labeled protein sample in the rehy-
dration buffer overnight at room temperature. Isoelectric
focusing (IEF) was performed using an Ettan™ IPGphor II
system (GE Healthcare) with oil immersion and paper
wicks at electrode contacts. The voltage profile used for
IEF was as follows: hold at 500 V for 1 hr, gradient to
1,000 V for 3 hrs, gradient to 3,000 V for 3 hrs, hold at
3,000 V for 2 hrs, gradient to 8,000 V for 3 hrs, at 8,000 V
for 10.5 hrs, and step to a final voltage of 500 V.
After the 1
st dimension separation, IEF strips were incu-
bated in equilibration buffer (6 M urea, 2% (w/v) SDS,
50 mM Tris-HCl (pH 8.8), 30% (v/v) glycerol, 0.002%
(w/v) BPB) containing DTT (10 mg/ml) for 20 min and
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iodoacetamide (25 mg/ml). The strips were loaded onto
10% Tris-glycine SDS-polyacrylamide gels and run at
15 W per gel by using an Ettan™ DALTsix electrophor-
esis unit (GE Healthcare). Scanning of the DIGE gels was
done using Typhoon 9400™ Variable Mode Imager (GE
Healthcare).
We employed the three-dye system with four biologi-
cally independent replicates using an independent Cy2 dye
channel as internal standard for each gel. The internal
standard was composed of an equal mixture of control
and test samples. The control and test samples used either
Cy3 or Cy5 with dye swapping. Gel image analysis was
performed using DeCyder™ 2-D differential analysis soft-
ware version 6.0 (GE Healthcare), with the peak detection
threshold set to an expected value of 2500 spots. Protein
spots were quantified using peak volumes calculated by
the DeCyder™ software. Each gel was normalized based
on the independent Cy2 channel using the differential in-
gel analysis (DIA) module. Biological variation analysis
(BVA) was done for four replicates, including 4 internal
standards, 4 controls and 4 test samples. Statistical analysis
of spots was performed by the Student’s t-test with FDR
(false discovery rate) correction as previously described
[48,49]. Average spot ratios for treated to control samples
were calculated based on spot volumes for each matched
spot, along with p-values. For the chromatin enrichment
analysis, we defined the average ratio normalized spot
volumes for the chromatin fraction vs. WCE as the enrich-
ment factor (EF). EF values were calculated by the DeCy-
der software as fold change (EF = chromatin abundance/
WCE) when chromatin abundance exceeded WCE abun-
dance for the target protein, and as a negative fold change
(EF = -WCE/chromatin abundance) otherwise. For experi-
ments comparing the MMS-treated vs. non-treated chro-
matin fraction, differential factors (DF) were similarly
calculated, where DF = (MMS treated/control) when trea-
ted ≥ control, and as a negative fold change (DF = -con-
trol/MMS treated) otherwise. As with the chromatin
abundance experiment, the average ratio of spot volumes
of the two DIGE channels being compared is reported.
Calculated enrichment factors (EF) provide a measure of
chromatin association (protein localization) independent
of total protein abundance, whereas the differential factors
(DF) measure changes in abundance in the chromatin
fraction, including both changes in total abundance in the
cell and changes in protein localization. For graphical pre-
sentation, a log scale is used and values are presented as
log2 (treated/control). To determine the magnitude of
change that is likely to be detected, a post-hoc power ana-
lysis was conducted using the statistical analysis package R
[50]. Standard deviations were calculated for all spots
appearing on 10 or more gel image channels (i.e. 10 from
12 total on 4 gels), and used to estimate the expected
detectable fold change with a power of 0.80 (b = 0.20).
Preparative 2D-PAGE
For preparative 2D-PAGE, 0.7 to 1.0 mg protein was sepa-
rated on large-format gels using a 24 cm IPG 4-7 strip for
1
st dimension separation and an SDS-PAGE gel for the
second dimension as described above. Preparative gels
were visualized by the colloidal Coomassie-staining
method [51] and scanned using a Typhoon 9400™ Vari-
able Mode Imager (GE Healthcare). Spots of interest were
matched between DIGE images and the preparative gel,
and spots manually excised for protein identification.
Spots were prioritized for identification using an FDR cor-
rected p-value cut-off of 0.05 and a change in expression
of 1.4 or greater.
Mass spectrometry
Protein spots excised from the preparative gel were cut
into approximately 1 mm
3 pieces, then reduced and alky-
lated by treatment with 10 mM DTT and 55 mM iodoace-
tamide in 50 mM ammonium bicarbonate buffer [52]. Gel
pieces were washed with 50 mM ammonium bicarbonate
buffer and dehydrated in a SpeedVac
® concentrator
(Savant) for 1 hr, soaked with 3-10 μlo f2 0n g / μlt r y p s i n
solution (sequencing grade modified trypsin, Promega) in
50 mM acetic acid on ice for 20 min, then washed again
with buffer. Protein digestion was performed in the same
buffer (50 μl) overnight at 35°C. Reaction supernatant was
recovered and gel pieces were further extracted by 2×
sonication in 50 μl 50% acetonitrile/1% trifluroacetic acid,
and then dried using a SpeedVac
® concentrator (Savant).
Mass spectrometry for higher abundance spots was per-
formed using a Waters micromass quadrupole time of
flight (Q-TOF) Ultima mass spectrometer with a nanos-
pray ESI injection at mass spectrometry facility in Univer-
sity of Waterloo. Samples analyzed using the Q-Tof were
desalted prior to analysis using C18 ZipTip
® pipette tips
(Millipore) and eluted using 50% acetonitrile in water with
0.2% formic acid. For lower abundance spots, trypsin-
digested peptides were analyzed (without ZipTip desalting)
using an Applied Biosystems Q-Trap mass spectrometry
system at the Proteomics Core Facility of Dalhousie
University (Halifax, Nova Scotia).
Protein identification
Protein identification was performed using Peaks Studio
(version 2.4, Bioinformatics Solutions, Waterloo), which
combines auto de novo sequencing and homology-based
database searching, with the non-redundant MSDB data-
base (Dr. D.N Perkins, Imperial College London, Release
20063108, 3239079 sequences). Mass error tolerances of
parental and fragment ions were set at 0.1 for Q-TOF
spectra and 0.3 or 0.4 for Q-Trap spectra, with 0.3 used if
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protein identifications were based on the Peaks database
search score (%) according to the algorithm of Ma et al.
(2005) [53]. Protein identifications were accepted if the
homology search score was higher than 80% (i.e. extre-
mely high confidence) and identified a single yeast pro-
tein. For Peaks scores less than 80%, protein identity was
additionally confirmed using the web-based Mascot
search engine (version 4) in the MS/MS ion search mod-
ule (Matrix Science, http://www.matrixscience.com) with
MSDB by restricted to Saccharomyces cerevisiae (10742
sequences) as the target organism. Protein matches were
retained if the Mascot search had a significance threshold
of p < 0.05, with default mass error tolerances of 1.2 and
0.6 Da for parental and fragment ions, respectively.
Finally, the false discovery rate (threshold set to 0.01) was
confirmed by performing the Mascot decoy database
search. For both the Peaks and Mascot database searches,
trypsin was set as the digestive protease allowing one
missed cleavage, and carbamidomethylation of cysteine
and oxidation of methionine were set as the fixed and
variable modifications, respectively. For counting number
of unique peptides matching to hit proteins, only peptide
ions that are doubly or triply charged were included. Pep-
tide sequence coverage (%) was obtained based on the
matching peptide sequences from Peaks.
Genotoxic sensitivity assays
To identify potential genotoxic effects of targeted proteins,
a spotting growth assay was performed to assess MMS or
hydroxyurea (HU) resistance [40,41] in gene knockout cell
lines or cells with lowered mRNA expression. Haploid
knockout and DAmP cell lines in a BY4741 background
were purchased from Open Biosystems (Thermo Fisher
Scientific Inc.). BY4741 wild type and DNA damage
checkpoint compromised rad53-11 [42] strains were used
as controls. Cultures of cells were grown to saturation (~2
×1 0
8 cells/ml) and serial 10-fold dilutions, ranging from
10
7 cells/ml to 10
4 cells/ml, were prepared for each strain.
5 μl of each dilution was spotted onto a series of YPD
plates with varying concentrations of MMS (up to 0.04%)
or HU (up to 100 mM). The plates were incubated at 30°C
for 2 days.
Additional material
Additional file 1: Supplementary figures 1-4, Supplementary Tables
1 and 2. Figure S1. DIGE gel image comparing chromatin fraction and
whole cell extract. Figure S2. DIGE gel image comparing MMS treated
and control chromatin fractions. Figure S3. Additional spotting growth
assay for genotoxic sensitivity. Figure S4. Western blot analysis of
chromatin fractionation samples. Table S1. Mass spectrometry data for
proteins identified in chromatin enriched sample. Table S2. Mass
spectrometric identification of MMS-induced differentially expressed
proteins.
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